Eosinophilia myalgia syndrome. The role of contaminants, the role of serotonergic metabolism set up.
Nicolodi
M
M
Interuniversity Centre of Neurochemistry, Florence University, Italy.
Sicuteri
F
F
D004340:Drug Contamination; D016603:Eosinophilia-Myalgia Syndrome / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology*; D005260:Female; D010134:Fenclonine / Q000627:therapeutic use; D005334:Fever; D006801:Humans; D008297:Male; D008881:Migraine Disorders / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D010146:Pain; D011985:Receptors, Serotonin / Q000502:physiology; D012189:Retrospective Studies; D012701:Serotonin / Q000378:metabolism* / Q000627:therapeutic use*; D018490:Serotonin Agents / Q000627:therapeutic use; D014364:Tryptophan / Q000494:pharmacology*
D011985:Receptors, Serotonin; D018490:Serotonin Agents; D012701:Serotonin; D014364:Tryptophan; D010134:Fenclonine